Partner News
The section includes updates from partner organizations on related advocacy efforts.
Materials in this section
ECDC: High Burden of Hepatitis B and C Persists in the EU/EEA
Recent ECDC data show that despite progress in prevention and control efforts, hepatitis B and C continue to pose significant public health challenges in the European Union and European Economic Area. More
Digitalized Community-led Monitoring - HIV/HBV/HCV in India and Indonesia
TREAT Asia/amfAR is implementing the Community-led Monitoring in Asia project, an online data dashboard to enhance ongoing community-led monitoring in India and Indonesia, including HBV and HCV indicators. More
Barriers to a Cure: Study Reveals Global Obstacles to Getting Hep C Treatment
A study provides new evidence regarding the registration and reimbursement of HCV therapies, including restrictions on reimbursement, permitting multicountry analyses and highlighting areas for growth. More
Progress Towards Elimination of Viral Hepatitis: a Lancet Gastroenterology & Hepatology Commission Update
The Commission update focuses on national progress among the 20 countries most heavily burdened with viral hepatitis (75% of the global burden). An effective response in these countries is crucial if global elimination targets are to be achieved. More
Driving Progress: Funding Hepatitis Elimination Programs for Lasting Impact
By addressing the funding gap through creative financing mechanisms, we can accelerate the progress towards eliminating hepatitis globally. More
World Health Organization Commends Egypt for its Progress on the Path to Eliminate Hepatitis C
Egypt has become the first country to achieve the “gold tier” status on the path to elimination of hepatitis C as per WHO criteria. More
Advocating for the Integration of Viral Hepatitis Prevention and Treatment for People Who Use Drugs in PEPFAR COPs
PEPFAR Watch webinar co-hosted by Treatment Action Group, World Hepatitis Alliance, Harm Reduction International, and the International Drug Policy Consortium. More
The Asia-Pacific Region Has the World’s Highest Burden of Hepatitis B
In an issue brief, amfAR’s TREAT Asia program responds to this urgent global public health emergency pointing out the scope of the problem and what’s needed for the prevention, care, and treatment of people at risk for or impacted by HBV. More
Viral Hepatitis B and C Policies in Countries and Burden of Disease in WHO Regions, 2023
In a fact sheet, WHO provides a status of the viral hepatitis testing and treatment policies as reported through the Global AIDS Monitoring in 2023. More
Chelsea Clinton: How to Eliminate Viral Hepatitis by 2030
Eliminating hepatitis B and C by 2030 will be impossible if donor investments don’t increase. And we aren’t just talking about billion-dollar investments. More